Suchergebnisse - "Hall, Michael J"

PubPharm (8)

1

Pancreatic cancer in the era of COVID-19 pandemic : Which one is the lesser of two evils?

enthalten in: World journal of clinical oncology | 2021

von Moslim, M. | Hall, M. | Meyer, J. | +1

2

Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2014

von Konski, A. | Meyer, J. | Joiner, M. | +10

3

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium

enthalten in: Investigational new drugs | 2010

von Kindler, H. | Wroblewski, K. | Wallace, J. | +6

4

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium

enthalten in: Investigational new drugs | 2010

von Kindler, H. | Wroblewski, K. | Wallace, J. | +6

5

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium

enthalten in: Investigational new drugs | 2010

von Kindler, H. | Wroblewski, K. | Wallace, J. | +6

6

Family History of Pancreatic Cancer in a High-Risk Cancer Clinic: Implications for Risk Assessment

enthalten in: Journal of genetic counseling | 2008

von Hall, M. | Dignam, J. | Olopade, O.

7

Family History of Pancreatic Cancer in a High-Risk Cancer Clinic: Implications for Risk Assessment

enthalten in: Journal of genetic counseling | 2008

von Hall, M. | Dignam, J. | Olopade, O.

8

Family History of Pancreatic Cancer in a High-Risk Cancer Clinic: Implications for Risk Assessment

enthalten in: Journal of genetic counseling | 2008

von Hall, M. | Dignam, J. | Olopade, O.

1
[1]